| Tag | Content |
|---|
EnhancerAtlas ID | HS078-02051 |
Organism | Homo sapiens |
Tissue/cell | H2171 |
Coordinate | chr1:229250210-229251130 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| TEAD1 | MA0090.2 | chr1:229250701-229250711 | ATGGAATGTG | - | 6.02 | | ZNF263 | MA0528.1 | chr1:229250887-229250908 | CTCCCCCCTCCCCGCTCCACC | - | 6.36 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_28465 | chr1:229249568-229251075 | Fetal_Intestine | | SE_39448 | chr1:229250007-229250639 | Jurkat | | SE_49840 | chr1:229247492-229251210 | RPMI-8402 | | SE_66415 | chr1:229250007-229250639 | Jurkat |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I229114 | chr1 | 229249753 | 229251596 |
|
Enhancer Sequence | TGCTCTCAGG ATGTTACATC CTGGTACAGT TGAGACAAGA AACAGGAAAC ACCACAGACA 60
CTATGATGAA CAATTGCAGA CGGTGCCGGG TGACAGATGA GGCAGTAAAT CCAGGCGAGG 120
GGTGAGGGCA GCTTGGCCAA GGTCCATACC ACTACTTAGT GCCTGGAAAG CATGCTCCAT 180
AAGGACGGGG ACTCTGTACC TGGGCTGCTA GGGCACCCGA GGGGCCACAG GCAGGCAATG 240
CACATTCACT GAAGATGTCA GTGGGTATTC CTTTCTCATC CGCCCAGCAC CAGACCCTGA 300
GCCCCTCAAG GGAAGAGATT ACTTATAATT TATCTCTGTA TGTCCTATAC CTGACCCATA 360
GCAATATGAG TGTGTCCCCC CAAAAGACCC ATTCTCCATC TCATCTTCAG GGAACATAAA 420
GCAGATCAGA GAAGGTAAGC CGCCTTCCTC CTCTCATTCA ATGCAAGAAA TGATGCACAG 480
CTGCTTTATC TATGGAATGT GACAAATGAC CTTGTATTTA TTCTACTTGG CTTAGCTCAT 540
CAGTGCTTTG CCAACTGTGT ATTGTGGCTC ATTTATCCAT CTGATACACC TTTATTGGAT 600
GTGCACAGAT GTCAGTGGCA CTGTGGATCA CCATAACTCC TCAAGTGGGA GCTGCCCCAG 660
CCTCCCTCCA AACCGAGCTC CCCCCTCCCC GCTCCACCCC ATCCCGCTCC CTGAAATCTG 720
ATCCCTCCCT GGAAGCACAC AGGAATCTTT CCTGTCTGGG AGACCACAGT ATCCCCAGTC 780
CCTAACACAG TGCCATGCTT ACAGCAGGGG CTTAGTCAAT GTTTTGCAGA TAAATGGGGC 840
CCTGCTGGGG ACTCAGGGGT GGGGTGCAAA GATGCATCAC ATTGGTGGTG CAACAGGATT 900
TGTTTGAAAG GCAGGGATAG 920
|
